Page last updated: 2024-08-25

n-methylscopolamine and Status Epilepticus

n-methylscopolamine has been researched along with Status Epilepticus in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fu, L; Liu, K; Mori, S; Nishibori, M; Takahashi, H; Teshigawara, K; Wake, H; Yoshino, T1
Canteras, NS; De Lima, TC; Duarte, FS; Duzzioni, M; Gavioli, EC; Hoeller, AA1
Baldwin, R; Lumley, L; Niquet, J; Norman, K; Suchomelova, L; Wasterlain, CG1
Andrade-Neto, M; Barros Viana, GS; Florençode Sousa, FC; França Fonteles, MM; Mendes Vasconcelos, SM; Silveira Macêdo, D; Vasconcelos Aguiar, LM1
Gordon, RK; Nambiar, MP; Ratcliffe, RH; Rezk, PE; Steele, KE; Tetz, LM1
Coulter, DA; Gibbs, JW; Holloway, KL; Lin, DD; Shumate, MD1

Other Studies

6 other study(ies) available for n-methylscopolamine and Status Epilepticus

ArticleYear
Therapeutic effects of anti-HMGB1 monoclonal antibody on pilocarpine-induced status epilepticus in mice.
    Scientific reports, 2017, 04-26, Volume: 7, Issue:1

    Topics: Animals; Antibodies, Monoclonal; Blood-Brain Barrier; Cerebral Cortex; Female; Hippocampus; HMGB1 Protein; Immunologic Factors; Mice, Inbred C57BL; N-Methylscopolamine; Pilocarpine; Status Epilepticus; Treatment Outcome

2017
NK1 receptors antagonism of dorsal hippocampus counteract the anxiogenic-like effects induced by pilocarpine in non-convulsive Wistar rats.
    Behavioural brain research, 2014, May-15, Volume: 265

    Topics: Analysis of Variance; Animals; Anticonvulsants; Dipeptides; Dose-Response Relationship, Drug; Hippocampus; Indoles; Male; Maze Learning; Muscarinic Agonists; N-Methylscopolamine; Parasympatholytics; Pilocarpine; Rats; Rats, Wistar; Status Epilepticus

2014
Midazolam-ketamine dual therapy stops cholinergic status epilepticus and reduces Morris water maze deficits.
    Epilepsia, 2016, Volume: 57, Issue:9

    Topics: Animals; Anticonvulsants; Brain; Cholinergic Agents; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Ketamine; Learning Disabilities; Lithium Chloride; Male; Maze Learning; Midazolam; N-Methylscopolamine; Pilocarpine; Rats; Rats, Sprague-Dawley; Status Epilepticus; Valproic Acid

2016
Differential effects of cocaine-induced seizures and lethality on M(1)-like muscarinic and dopaminergic D (1)- and D (2)-like binding receptors in mice brain.
    Cellular and molecular neurobiology, 2006, Volume: 26, Issue:1

    Topics: Acetylcholinesterase; Animals; Benzazepines; Binding Sites; Brain; Cocaine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Humans; Male; Mice; N-Methylscopolamine; Parasympatholytics; Receptor, Muscarinic M1; Receptors, Dopamine D1; Receptors, Dopamine D2; Spiperone; Status Epilepticus

2006
Development of a rat pilocarpine model of seizure/status epilepticus that mimics chemical warfare nerve agent exposure.
    Toxicology and industrial health, 2006, Volume: 22, Issue:6

    Topics: Animals; Anticonvulsants; Behavior, Animal; Body Temperature; Brain; Chemical Warfare Agents; Cholinergic Antagonists; Drug Evaluation, Preclinical; Electroencephalography; Heart Rate; Lethal Dose 50; Lithium Chloride; Male; Models, Animal; Motor Activity; Muscarinic Agonists; N-Methylscopolamine; Neuroprotective Agents; Neurotoxicity Syndromes; Pilocarpine; Rats; Rats, Sprague-Dawley; Seizures; Soman; Status Epilepticus

2006
GABA(A) receptor function in epileptic human dentate granule cells: comparison to epileptic and control rat.
    Epilepsy research, 1998, Volume: 32, Issue:1-2

    Topics: Animals; Dentate Gyrus; Epilepsy, Temporal Lobe; GABA Agonists; GABA Antagonists; gamma-Aminobutyric Acid; Humans; Male; N-Methylscopolamine; Neurons; Pilocarpine; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Status Epilepticus; Temporal Lobe; Zinc

1998